QCM
BBIO icon

Quantinno Capital Management’s BridgeBio Pharma BBIO Stock Holding History

Quantinno Capital Management’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.85M Buy
38,202
+5,962
+18% +$418K ﹤0.01% 1672
2026
Q1 		$2.39M Buy
32,240
+21,464
+199% +$1.56M ﹤0.01% 1512
2025
Q4 		$824K Buy
10,776
+3,072
+40% +$202K ﹤0.01% 1948
2025
Q3 		$400K Buy
+7,704
New +$376K ﹤0.01% 2213

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Quantinno Capital Management's BBIO Position: Q2 2026 in Review

Quantinno Capital Management increased its BridgeBio Pharma (BBIO) stake by 18% in Q2 2026, buying an estimated $418K and bringing the position to 38,202 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #1672.

Quantinno Capital Management first reported a position in BBIO in Q3 2025 and has held it in 4 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Quantinno Capital Management held 38,202 shares of BridgeBio Pharma worth $2.85M as of Q2 2026.
  • Quantinno Capital Management bought 5,962 BridgeBio Pharma shares in Q2 2026, an estimated $418K.
  • BridgeBio Pharma made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1672 holding.
  • Quantinno Capital Management first reported a position in BridgeBio Pharma in Q3 2025 and has held it in 4 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.